Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.

Dongjun JeongHyeongjoo KimSeona BanSeunghyun OhSanghee JiDoyeon KimTae Sung AhnHan Jo KimSang Byung BaeHyog Young KwonJungkyun ImMoon Soo LeeHyun Deuk ChoChang-Jin KimDongjun Jeong

Published in: Journal of cancer research and clinical oncology (2017)

KPNA2 expression is useful for identification of patients with high-risk stage II CRC who could benefit from AC and that KPNA2 may also be a promising therapeutic target.

Keyphrases

poor prognosis
bioinformatics analysis
binding protein